Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | 0.040 | 4 | 24360918 | intergenic variant | T/C | snv | 0.18 |
|
Nervous System Diseases | 0.730 | 0.667 | 3 | 2016 | 2018 | |||||||
|
1.000 | 0.040 | 4 | 23795377 | 3 prime UTR variant | C/T | snv | 0.53 |
|
Nervous System Diseases | 0.020 | 1.000 | 2 | 2011 | 2018 | |||||||
|
1.000 | 0.040 | 4 | 23961338 | intergenic variant | G/A | snv | 0.31 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.080 | 4 | 23864492 | intron variant | A/G | snv | 0.11 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.925 | 0.120 | 4 | 23961283 | intergenic variant | A/C | snv | 6.9E-02 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.925 | 0.120 | 4 | 23961283 | intergenic variant | A/C | snv | 6.9E-02 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 4 | 23966672 | regulatory region variant | A/G | snv | 0.13 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.925 | 0.120 | 4 | 23966759 | regulatory region variant | C/A | snv | 5.4E-02 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.925 | 0.120 | 4 | 23966759 | regulatory region variant | C/A | snv | 5.4E-02 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 4 | 24130930 | intergenic variant | G/A;C | snv |
|
Mental Disorders | 0.700 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
0.925 | 0.120 | 4 | 23949395 | regulatory region variant | C/G | snv | 0.20 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.925 | 0.120 | 4 | 23949395 | regulatory region variant | C/G | snv | 0.20 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Musculoskeletal Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.925 | 0.120 | 4 | 23949395 | regulatory region variant | C/G | snv | 0.20 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Musculoskeletal Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
4 | 24112424 | intergenic variant | A/G | snv | 0.20 |
|
0.700 | 1.000 | 1 | 2013 | 2013 | ||||||||||
|
1.000 | 0.040 | 4 | 23968416 | intergenic variant | C/G | snv | 0.12 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
4 | 24065360 | intergenic variant | G/A;C;T | snv |
|
0.700 | 1.000 | 1 | 2013 | 2013 | |||||||||||
|
1.000 | 0.040 | 4 | 23848945 | intron variant | C/T | snv | 5.8E-03 |
|
Mental Disorders | 0.700 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.882 | 0.040 | 4 | 23824109 | intron variant | T/A;G | snv |
|
Digestive System Diseases | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||||||
|
0.882 | 0.040 | 4 | 23824109 | intron variant | T/A;G | snv |
|
Digestive System Diseases | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||||||
|
0.882 | 0.040 | 4 | 23824109 | intron variant | T/A;G | snv |
|
0.010 | 1.000 | 1 | 2008 | 2008 | |||||||||
|
1.000 | 0.040 | 4 | 23964419 | intergenic variant | A/G | snv | 0.14 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 4 | 23953895 | intergenic variant | A/C | snv | 0.33 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 4 | 23815404 | intron variant | A/C;G | snv | 0.39 |
|
Nervous System Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
4 | 23825622 | intron variant | A/T | snv | 0.63 |
|
0.700 | 1.000 | 1 | 2013 | 2013 | ||||||||||
|
4 | 23891394 | intron variant | A/G | snv | 0.49 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2017 | 2017 |